Restarting Antipsychotic Medication After Discontinuation

Rationale for Direct Restart

• The INTEGRATE guidelines emphasize acting early and using therapeutic doses for at least 4 weeks to assess efficacy in the inpatient setting with active psychotic symptoms 1

Managing Antipsychotic Switching

• The INTEGRATE guidelines recommend gradual cross-titration when switching antipsychotics, informed by half-life and receptor profiles 1
• For switching from aripiprazole to paliperidone, begin paliperidone 6mg while simultaneously tapering aripiprazole over 5-7 days, given aripiprazole's long half-life of 75 hours 1

Monitoring Requirements

• Assess treatment response at 4 weeks minimum at the therapeutic dose with documented adherence 1
• Document baseline and ongoing assessment of extrapyramidal symptoms, weight, metabolic parameters 2
• If significant positive symptoms persist after 4 weeks at 6mg with confirmed adherence, consider switching to an alternative antipsychotic with different pharmacodynamic profile 1
• The inpatient setting allows for close monitoring during this critical transition period 3